| Date | Title | Description |
| 24.02.2024 | Insamo Raises $12 Million To Pioneer The Discovery Of Membrane-Permeable And Orally Available Cyclic-Peptides | Insamo – a biotechnology company pioneering the discovery of membrane-permeable and orally available cyclic peptides – announced $12 million in seed capital from Playground Global, venBio, and MRL Ventures Fund (MRLV). Sahsen Ventures, BEVC... |
| 23.02.2024 | Insamo's $12M Seed Funding Sparks Innovation in Biotechnology | Insamo, a Berkeley-based biotechnology company, recently secured $12 million in seed funding, igniting excitement in the industry. Led by a team of visionaries, including Tim Craven, Toby Passioura, and Glen McIntyre, Insamo is revolutioniz... |
| 21.02.2024 | Insamo Raises $12M in Seed Funding | From left to right: Tim Craven (CEO); Toby Passioura (CSO); Glen McIntyre (COO). (Photo: Business Wire)
Insamo, a Berkeley, CA-based biotechnology company advancing membrane-permeable and orally available cyclic-peptides, raised $12M in See... |
| 21.02.2024 | Exclusive: How emerging manager Overture VC raised $60 million—yes, in this economy | Fundraising right now is zero fun.
Obvious, I know, but it bears repeating—if you’re a VC, especially an emerging manager, you’re contending with high interest rates, anxious LPs, and far-reaching economic uncertainty while trying to raise ... |
| 21.02.2024 | Insamo Launches with $12M Funding |
BERKELEY, CA, Insamo, a biotechnology company, announced $12 million in seed capital.
>> Click here for more funding data on Insamo
>> To export Insamo funding data to PDF and Excel, click here
Insamo, a biotechnology com... |
| - | Insamo | “Insamo is a global biotechnology company pioneering the discovery of membrane-permeable and orally available cyclic-peptides with antibody-like binding affinity. ” |
